Last $40.47 USD
Change Today +0.59 / 1.48%
Volume 522.5K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 12:55 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Terrance H. Gregg

Chief Executive Officer and Director, DexCom, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 8 different industries.

See Board Relationships
65$4,296,556
As of Fiscal Year 2013

Background*

Mr. Terrance H. Gregg, also known as Terry, has been the Chief Executive Officer of DexCom, Inc. since June 2007. Mr. Gregg has been a Special Venture Partner at Galen Partners since 2002. He served as the President of DexCom, Inc. from June 2007 to June 1, 2011. He served as the Chief Executive Officer and President of Vasogen, Inc. from March 7, 2007 to June 20, 2007. He served as the Chief Operating Officer of Medtronic MiniMed, Inc. (also known as MiniMed, Inc.) ...

Read Full Background

Corporate Headquarters*

6340 Sequence Drive
San Diego, California 92121

United States

Phone: 858-200-0200
Fax: --

Board Members Memberships*

Former Director
Former Chairman of the Board
Executive Chairman
1998-N/A
Former President, Chief Operating Officer, Office of the Chief Executive and Director
1999-N/A
Former Director, Chairman of Organization and Compensation Committee and Member of Audit Committee
1999-2009
Former Chairman, Chairman of Compensation, Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Special Committee
2001-2006
Former Director, Member of Compensation & Human Resources Committee and Member of Nominating & Governance Committee
2002-2003
Former Director
2004-2008
Former Director and Member of Audit Committee
2005-Present
Chief Executive Officer and Director

Education*

BS 1971
Colorado State University

Other Affiliations*

Annual Compensation*

Salary$420,000
Total Annual Compensation$420,000

Stock Options*

Restricted Stock Awards$2,846,216
All Other Compensation$13,152
Exercised Options105,000
Exercised Options Value$2,975,626
Exercisable Options1,571,890
Exercisable Options Value$44,354,909
Total Value of Options$47,330,535
Total Number of Options1,676,890

Total Compensation*

Total Annual Cash Compensation$1,450,340
Total Short Term Compensation$420,000
Other Long Term Compensation$2,859,368
Total Calculated Compensation$4,296,556
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $40.47 USD +0.59

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$347.5K
Eyal Shalom Chief Executive Officer
RadView Software Ltd.
--
Lisa A. Hook Chief Executive Officer, President, Director and Member of Neutrality Committee
NeuStar, Inc.
$698.0K
Duane DeSisto Chief Executive Officer, President and Director
Insulet Corporation
$448.4K
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$472.1K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.